# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Laidlaw & Co. analyst Yale Jen initiates coverage on BiomX (AMEX:PHGE) with a Buy rating and announces Price Target of $...
HC Wainwright & Co. analyst Joseph Pantginis reiterates BiomX (AMEX:PHGE) with a Buy and maintains $2 price target.